Additionally, FOXM1 has been shown to be overexpressed on the mRNA and protein levels in bladder cancer cells, and plays an important role in cisplatin resistance, outcome prediction, and risk stratification of patients with BLCA [29]. The gene discussed is FOXM1; the disease is bladder transitional cell carcinoma.